ELK Biotechnology
Choactase Rabbit Polyclonal Antibody - ES1975
Choactase Rabbit Polyclonal Antibody - ES1975
Couldn't load pickup availability
Choactase Rabbit Polyclonal Antibody
Sizes: 50μL, 100μL
Catalogue Numbers: ES1975-50, ES1975-100
Lead times: 1-2 weeks, if manufacturer has product in stock
Manufacturer/Ship Location: China
Background: This gene encodes an enzyme which catalyzes the biosynthesis of the neurotransmitter acetylcholine. This gene product is a characteristic feature of cholinergic neurons, and changes in these neurons may explain some of the symptoms of Alzheimer's disease. Polymorphisms in this gene have been associated with Alzheimer's disease and mild cognitive impairment. Mutations in this gene are associated with congenital myasthenic syndrome associated with episodic apnea. Multiple transcript variants encoding different isoforms have been found for this gene, and some of these variants have been shown to encode more than one isoform. [provided by RefSeq, May 2010],
Reactivity: Human, Mouse, Rat
Host: Rabbit
Applications: WB, ELISA
Alternate Names: CHAT, Choline O-acetyltransferase, CHOACTase, ChAT, Choline acetylase
Clonality: Polyclonal
Immunogen: The antiserum was produced against synthesized peptide derived from human Choactase. AA range:334-383
Isotype: IgG
Target: Choactase
Specificity: Choactase Polyclonal Antibody detects endogenous levels of Choactase protein.
Dilution: Western Blot: 1/500 - 1/2000. ELISA: 1/10000. Not yet tested in other applications.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/ml,
Formlation: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Expression: Brain, Lymphocyte, Placenta, Spinal cord,
Observed Band (KD): 82,70kD
Fields: Glycerophospholipid metabolism, Cholinergic synapse
Function: Catalytic Activity: Acetyl-CoA + choline = CoA + O-acetylcholine
Disease: Defects in CHAT are the cause of congenital myasthenic syndrome with episodic apnea (CMSEA) [MIM: 254210], formerly known as familial infantile myasthenia gravis 2 (FIMG2). CMSEA is an autosomal recessive congenital myasthenic syndrome. Patients have myasthenic symptoms since birth or early infancy, negative tests for anti-AChR antibodies, and abrupt episodic crises with increased weakness, bulbar paralysis, and apnea precipitated by undue exertion, fever, or excitement
Function: Catalyzes the reversible synthesis of acetylcholine (ACh) from acetyl CoA and choline at cholinergic synapses
Online Information: Choline acetyltransferase entry,Similarity: Belongs to the carnitine/choline acetyltransferase family
Subcellular Location: nucleus, cytoplasm, cytosol, presynapse,
Storage and Stability: -20°C/1 year
Gene Name: CHAT
Protein Name: Choline O-acetyltransferase
Mouse SwissProt Number: Q03059
Rat SwissProt Number: P32738
Research Use Only
